AbbVie Inc.

Last updated September 27, 2026

Favorite this organization

Organization details

Legal name: AbbVie Inc.
Ownership: Public
Status: Active
Sector (GICS): Health Care
SIC code: 2834 — Pharmaceutical Preparations
Jurisdiction of incorporation: Delaware
Headquarters city: North Chicago
Headquarters state / province: Illinois
Headquarters country: United States
Fiscal year end: December
Ticker symbol: ABBV
Primary stock exchange: NYSE

Identifiers

SEC CIK: 0001551152
EIN: 32-0375147
Wikidata ID: Q14662364

Board of directors

Follow this board

Brett J. Hart · Director
Since 2023
Edward J. Rapp · Director
Since 2023
Frederick H. Waddell · Director
Since 2023
Glenn F. Tilton · Director
Since 2023
Jennifer L. Davis · Director
Since 2023
John Carethers · Director
Since 2026
Melody B. Meyer · Director
Since 2023
Rebecca B. Roberts · Director
Since 2023
Richard A. Gonzalez · Director · EXECUTIVE CHAIRMAN OF BOARD
Since 2023
Robert A. Michael · Director · CHAIRMAN OF THE BOARD AND CEO
Since 2025
Robert J. Alpern · Director
Since 2023
Roxanne S. Austin · Director
Since 2023
Susan E. Quaggin · Director
Since 2023
Thomas C. Freyman · Director
Since 2023
Thomas J. Falk · Director
Since 2025
William H.l. Burnside · Director
Since 2023

Chief executives

Robert A. Michael · CHIEF EXECUTIVE OFFICER

Since July 2024

55 CEO score

Mixed · grade D

Out of 100, from shareholder return, dividends, growth and acquisitions.

Partial: only 50% of the scoring weight is on file.

Dividends 15%: 69
Revenue growth 20%: 67
Earnings growth 15%: 26

50% of the scoring weight is on file. Figures cover December 2023 – December 2025.

Richard A. Gonzalez · CHAIRMAN OF THE BOARD AND CEO

2013 – 2024 · Former

61 CEO score

Solid · grade C

Out of 100, from shareholder return, dividends, growth and acquisitions.

Partial: only 35% of the scoring weight is on file.

Revenue growth 20%: 80
Earnings growth 15%: 36

35% of the scoring weight is on file. Figures cover December 2012 – December 2023.

Director election results

Annual meeting of May 8, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

9 of this board's directors also sit on 12 other boards. 3 are in the same sector.

Shared director Other board Same sector

Abbott Laboratories Same sector
via Robert J. Alpern
Align Technology Inc. Same sector
via Jennifer L. Davis
Avantor Inc.
via John Carethers
Black Hills Corporation
via Rebecca B. Roberts
CrowdStrike Holdings Inc.
via Roxanne S. Austin
Freshworks Inc.
via Roxanne S. Austin
International Business Machines Corporation
via Frederick H. Waddell
Lockheed Martin Corporation
via Thomas J. Falk
MSA Safety Incorporated Same sector
via Rebecca B. Roberts
Phillips 66
via Glenn F. Tilton
Verizon Communications Inc.
via Roxanne S. Austin
Xos Inc.
via Edward J. Rapp

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months: $0; 0 purchases by 0 insiders
Sold, last 12 months: $18,922,198; 6 sales by 3 insiders

Date	Insider	Transaction	Shares	Price	Value
Aug 14, 2026	Donoghoe Nicholas Officer (EVP, CHIEF BUS/STRAT OFFICER)	Option exercise	+32,710	$79.02	$2,584,744
Aug 14, 2026	Donoghoe Nicholas Officer (EVP, CHIEF BUS/STRAT OFFICER)	Open-market sale	−32,710	$250.00	$8,177,500
May 8, 2026	Thomas J. Falk Director	Grant or award	+1,118	—	—
May 8, 2026	Frederick H. Waddell Director	Grant or award	+1,118	—	—
May 8, 2026	Rebecca B. Roberts Director	Grant or award	+1,118	—	—
May 8, 2026	Edward J. Rapp Director	Grant or award	+1,118	—	—
May 8, 2026	Susan E. Quaggin Director	Grant or award	+1,118	—	—
May 8, 2026	Melody B. Meyer Director	Grant or award	+1,118	—	—
May 8, 2026	Brett J. Hart Director	Grant or award	+1,118	—	—
May 8, 2026	Thomas C. Freyman Director	Grant or award	+1,118	—	—
May 8, 2026	Jennifer L. Davis Director	Grant or award	+1,118	—	—
May 8, 2026	William H.l. Burnside Director	Grant or award	+1,118	—	—
May 8, 2026	Roxanne S. Austin Director	Grant or award	+1,118	—	—
Mar 4, 2026	Purdue David Ryan Officer (SVP, Controller)	Open-market sale	−5,230	$233.56	$1,221,519
Mar 2, 2026	Siatis Perry C Officer (EVP, GC AND SECRETARY)	Open-market sale	−5,777	$233.51	$1,348,987

Peers

Compare boards

Organizations in the same sector, closest in location and size first.

3M Company NYSE: MMM · ST Paul, United States Organization ABVC BioPharma Inc. Nasdaq: ABVC · Fremont, United States Organization ACADIA Pharmaceuticals Inc. Nasdaq: ACAD · SAN Diego, United States Organization ADMA Biologics Inc Nasdaq: ADMA · Ramsey, United States Organization

Questions about AbbVie Inc.

Who is the CEO of AbbVie Inc.?

Robert A. Michael has been AbbVie Inc.'s CHIEF EXECUTIVE OFFICER since July 2024.

How many directors are on AbbVie Inc.'s board?

AbbVie Inc.'s board has 16 directors: Brett J. Hart, Edward J. Rapp, Frederick H. Waddell, Glenn F. Tilton, Jennifer L. Davis, John Carethers, Melody B. Meyer, Rebecca B. Roberts, Richard A. Gonzalez, Robert A. Michael and 6 others.

Are AbbVie Inc. insiders buying or selling shares?

Over the last 12 months, AbbVie Inc. insiders made no open-market purchases and sold $18.9 million of shares in 6 sales on the open market, as reported to the SEC on Forms 4 and 5.

How is AbbVie Inc. connected to…? → Spot something wrong? Report a correction

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="abbvie-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

No reviews yet. Be the first to write one.